Table 4.
DR1-restricted T Cell Hybridomas Are Specific for the hCII(262–270) Core Determinant
| T cell hybridoma | IL-2* | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human CII Mimotope Peptides‡ | ||||||||||||
| CII(250–264) | CII(253–267) | CII(256–270) | CII(259–273) | CII(262–276) | CII(265–279) | |||||||
| DR1hCII-2 | –§ | – | 2,560 | 2,560 | 1,280 | – | ||||||
| DR1hCII-3 | – | – | 2,560 | 2,560 | 2,560 | – | ||||||
| DR1hCII-5 | – | – | 640 | 1,280 | 1,280 | – | ||||||
| DR1hCII-14 | – | – | 1,280 | 2,560 | 1,280 | – | ||||||
| DR1hCII-19 | – | – | 2,560 | >2,560 | 640 | – | ||||||
Production of IL-2 was measured as an indicator of T cell hybridoma stimulation in an antigen presentation assay using DR1-expressing APCs, (cell line L57). After 24 h of culture, supernatants were collected and tested for the presence of IL-2–dependent cell line HT-2, as described in Materials and Methods. Data are expressed as units of IL-2 per milliliter.
Peptides were derived from the same Mimotope peptide synthesis used in Fig. 6.
–, <20 U/ml of IL-2 produced.